Ondansetron Pharmacokinetics in Pregnant Women and Neonates: Towards a New Treatment for Neonatal Abstinence Syndrome

E-ISSN： 1532-6535|97|2|167-176

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.2, 2015-02, pp. : 167-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opioid Maintenance Treatment during Pregnancy: Occurrence and Severity of Neonatal Abstinence Syndrome

European Addiction Research, Vol. 15, Iss. 3, 2009-03 ,pp. : 128-134

Karger

Access to resources Recommend Favorite

Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome

ACTA PAEDIATRICA, Vol. 104, Iss. 5, 2015-05 ,pp. : e188-e194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiretroviral Pharmacokinetics in Pregnant Women

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 277-0008, Iss. 9, 2015-09 ,pp. : 838-855

John Wiley & Sons Inc

Access to resources Recommend Favorite

Home‐based detoxification for neonatal abstinence syndrome reduces length of hospital admission without prolonging treatment

ACTA PAEDIATRICA, Vol. 103, Iss. 6, 2014-06 ,pp. : 601-604

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants

Journal of Developmental Origins of Health and Disease, Vol. 3, Iss. 4, 2012-04 ,pp. : 262-270

Cambridge University Press

Access to resources Recommend Favorite